ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,609Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 212

$531K Total Retail Price of All Prescriptions

Rank: 16 out of 212

354 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 354 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 354 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,498 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 500 453 1 1
LISINOPRIL 438 418 2 2
LEVOTHYROXINE SODIUM 273 249 3 7
METFORMIN HCL ER 271 243 4 34
LOSARTAN POTASSIUM 251 238 5 4
METOPROLOL SUCCINATE 222 198 6 14
GLIPIZIDE XL 215 198 7 88
HYDROCHLOROTHIAZIDE 209 204 8 8
ALLOPURINOL 207 192 9 18
FUROSEMIDE 183 177 10 11
OMEPRAZOLE 177 146 11 9
ATORVASTATIN CALCIUM 174 152 12 6
JANUVIA 174 162 12 35
LOVASTATIN 160 148 14 12
HYDROCODONE-ACETAMINOPHEN 139 101 S3 15 10
METOPROLOL TARTRATE 139 126 15 17
ATENOLOL 138 119 17 13
DONEPEZIL HCL 132 132 18 25
TAMSULOSIN HCL 128 128 19 21
ACTOS 124 116 20 68
FELODIPINE ER 123 123 21 36
CARVEDILOL 120 117 22 23
METFORMIN HCL 107 104 23 5
WARFARIN SODIUM 103 103 24 19
DIGOXIN 94 94 25 41
CLOPIDOGREL 93 93 26 31
AMLODIPINE BESYLATE-BENAZEPRIL 92 90 27 30
NAMENDA 87 87 28 28
AMLODIPINE BESYLATE 87 80 28 3
FLUTICASONE PROPIONATE 82 65 30 48
FENOFIBRATE 80 80 31 58
ALENDRONATE SODIUM 79 66 32 16
PANTOPRAZOLE SODIUM 77 63 33 44
PLAVIX 72 72 34 54
ADVAIR DISKUS 67 62 35 33
MIRTAZAPINE 66 62 36 43
DILTIAZEM ER 65 53 37 125
RANITIDINE HCL 65 59 37 29
ISOSORBIDE MONONITRATE ER 64 53 39 78
GABAPENTIN 61 20 40 22
DIOVAN 61 50 40 32
POTASSIUM CHLORIDE 60 59 42 27
NOVOLOG MIX 70-30 FLEXPEN 60 53 42 186
GLIPIZIDE ER 56 56 44 55
TRAMADOL HCL 56 49 44 50
VERAPAMIL ER 55 51 46 99
PIOGLITAZONE HCL 54 50 R 47 117
ACARBOSE 52 52 48 153
GLIPIZIDE 50 50 49 38
DILTIAZEM 24HR CD 50 50 49 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.